Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gale

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 4, 2019
2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 diseaseJessica Davidson, Elizabeth Molitor, Samantha Moores, et al.
Transplantation and Cellular Therapy|September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell TransplantationNicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
The Journal of Clinical Investigation|August 9, 2008
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsSteven J Howe, Marc R Mansour, Kerstin Schwarzwaelder, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Science (New York, N.Y.)|April 29, 2017
Community network for deaf scientistsHenry J Adler, Kelsey L Anbuhl, Samuel R Atcherson, et al.
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Nature Communications|January 5, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Nature Communications|October 30, 2021
Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 4, 2019
2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 diseaseJessica Davidson, Elizabeth Molitor, Samantha Moores, et al.
Transplantation and Cellular Therapy|September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell TransplantationNicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
The Journal of Clinical Investigation|August 9, 2008
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsSteven J Howe, Marc R Mansour, Kerstin Schwarzwaelder, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Science (New York, N.Y.)|April 29, 2017
Community network for deaf scientistsHenry J Adler, Kelsey L Anbuhl, Samuel R Atcherson, et al.
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Nature Communications|January 5, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Nature Communications|October 30, 2021
Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Pageof 37